Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,400 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 5 February 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download: 

(PDF, 3MB, 197 pages)

 

Export 10 results:
Author Title Type [ Year(Asc)]
Filters: Author is Hawley, S.  [Clear All Filters]
2019
S. Hawley, Edwards, C. J., Arden, N. K., Delmestri, A., Cooper, C., Judge, A., and Prieto-Alhambra, D., “Descriptive epidemiology of hip and knee replacement in rheumatoid arthritis: an analysis of UK electronic medical records”, Semin Arthritis Rheum, 2019.
2018
S. Hawley, Cordtz, R., Dreyer, L., Edwards, C. J., Arden, N. K., Delmestri, A., Silman, A., Cooper, C., Judge, A., and Prieto-Alhambra, D., “Association between NICE guidance on biologic therapies with rates of hip and knee replacement among rheumatoid arthritis patients in England and Wales: An interrupted time-series analysis”, Semin Arthritis Rheum, vol. 47, pp. 605-610, 2018.
S. Khalid, Calderon-Larranaga, S., Hawley, S., Ali, M. S., Judge, A., Arden, N., Van Staa, T., Cooper, C., Javaid, M. K., and Prieto-Alhambra, D., “Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on "real-world" data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database”, Clin Epidemiol, vol. 10, pp. 1417-1431, 2018.
E. Martin-Merino, Calderon-Larranaga, A., Hawley, S., Poblador-Plou, B., Llorente-Garcia, A., Petersen, I., and Prieto-Alhambra, D., “The impact of different strategies to handle missing data on both precision and bias in a drug safety study: a multidatabase multinational population-based cohort study”, Clin Epidemiol, vol. 10, pp. 643-654, 2018.
C. Garriga, Pazianas, M., Hawley, S., Delmestri, A., Prieto-Alhambra, D., Cooper, C., and Judge, A., “Oral bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study”, Ann N Y Acad Sci, vol. 1415, pp. 34-46, 2018.
E. Martin-Merino, Petersen, I., Hawley, S., Alvarez-Gutierrez, A., Khalid, S., Llorente-Garcia, A., Delmestri, A., Javaid, M. K., van Staa, T. P., Judge, A., Cooper, C., and Prieto-Alhambra, D., “Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK”, Osteoporos Int, vol. 29, pp. 467-478, 2018.
2017
J. Leal, Gray, A. M., Hawley, S., Prieto-Alhambra, D., Delmestri, A., Arden, N. K., Cooper, C., Javaid, M. K., and Judge, A., “Cost-Effectiveness of Orthogeriatric and Fracture Liaison Service Models of Care for Hip Fracture Patients: A Population-Based Study”, J Bone Miner Res, vol. 32, pp. 203-211, 2017.
A. Shah, Prieto-Alhambra, D., Hawley, S., Delmestri, A., Lippett, J., Cooper, C., Judge, A., and Javaid, M. K., “Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study”, Osteoporos Int, vol. 28, pp. 169-178, 2017.
2016
S. Hawley, Leal, J., Delmestri, A., Prieto-Alhambra, D., Arden, N. K., Cooper, C., Javaid, M. K., and Judge, A., “Anti-Osteoporosis Medication Prescriptions and Incidence of Subsequent Fracture Among Primary Hip Fracture Patients in England and Wales: An Interrupted Time-Series Analysis”, J Bone Miner Res, vol. 31, pp. 2008-2015, 2016.
A. Judge, Javaid, M. K., Leal, J., Hawley, S., Drew, S., Sheard, S., Prieto-Alhambra, D., Gooberman-Hill, R., Lippett, J., Farmer, A., Arden, N., Gray, A., Goldacre, M., Delmestri, A., and Cooper, C., “Models of care for the delivery of secondary fracture prevention after hip fracture: a health service cost, clinical outcomes and cost-effectiveness study within a region of England”, Health Services and Delivery Research, vol. No. 4.28, 2016.
[Page last reviewed 5 February 2020]